VC
CLX icon

Veracity Capital’s Clorox CLX Stock Holding History

Veracity Capital’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-1,689
Closed -$208K – 241
2025
Q3 		$208K Buy
+1,689
New +$210K 0.07% 236
2025
Q2 		– Sell
-1,657
Closed -$244K – 246
2025
Q1 		$244K Sell
1,657
-7
-0.4% -$1.07K 0.09% 196
2024
Q4 		$270K Buy
1,664
+2
+0.1% +$327 0.1% 187
2024
Q3 		$271K Buy
+1,662
New +$246K 0.1% 174
2022
Q1 		– Sell
-1,381
Closed -$241K – 237
2021
Q4 		$241K Buy
1,381
+1
+0.1% +$167 0.1% 209
2021
Q3 		$229K Buy
1,380
+100
+8% +$17.2K 0.1% 213
2021
Q2 		$230K Sell
1,280
-1,280
-50% -$234K 0.05% 222
2021
Q1 		$494K Hold
2,560
– – 0.11% 192
2020
Q4 		$516K Sell
2,560
-1,086
-30% -$225K 0.13% 178
2020
Q3 		$766K Sell
3,646
-3,260
-47% -$726K 0.21% 120
2020
Q2 		$1.51M Buy
6,906
+3,404
+97% +$680K 0.42% 72
2020
Q1 		$607K Sell
3,502
-10,754
-75% -$1.78M 0.18% 101
2019
Q4 		$2.19M Buy
+14,256
New +$2.13M 0.57% 38

Other funds holding CLX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Veracity Capital's CLX Position: Q4 2025 in Review

Veracity Capital sold out of Clorox (CLX) in Q4 2025, closing a stake of 1,689 shares — an estimated $208K sold.

Veracity Capital first reported a position in CLX in Q4 2019 and held it in 13 quarters. The position peaked at $2.19M in Q4 2019. 1,049 funds tracked by Wall St. Rank hold CLX as of Q4 2025.

  • Veracity Capital reported no remaining Clorox position as of Q4 2025 after selling out during the quarter.
  • Veracity Capital sold 1,689 Clorox shares in Q4 2025, an estimated $208K.
  • Veracity Capital first reported a position in Clorox in Q4 2019 and held it in 13 quarters.
  • Veracity Capital's Clorox position peaked at $2.19M in Q4 2019.
  • 1,049 funds tracked by Wall St. Rank held Clorox as of Q4 2025.

Based on Veracity Capital's 13F filing for Q4 2025, filed 29 Jan 2026.